Evaluation of physicians' approaches for the management of patients with diabetes during Ramadan in Iraq

Alabbood, Majid; Alameri, Rafid; Alsaffar, Yasameen

doi:10.1016/j.diabres.2022.110188

Cited by 2 publications

(4 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The approaches adopted by Iraqi physicians for the management of diabetes during Ramadan were evaluated in a cross-sectional online survey based (2021). 43 The participants were specialist doctors from different regions in Iraq who were directly involved in managing people with diabetes. Most participants were family physicians, followed by internists and endocrinologists.…”

Section: Resultsmentioning

confidence: 99%

Ramadan Fasting and Diabetes (2022): The Year in Review

Hafidh

Besheya

Elmehdawi

et al. 2023

Journal of Diabetes and Endocrine Practice

View full text Add to dashboard Cite

Objectives The literature on the impact of Ramadan fasting (RF) on metabolic control and health in people with diabetes is widely spread in many journals making it not readily accessible to those interested in the subject. We aimed to provide a narrative overview of the global literature production in 1 year (2022) on diabetes and RF. Materials and Methods It is a narrative, non-systematic review of the international literature from a single major medical online database (i.e., PubMed) in one calendar year (2022). Relevant literature was narrated in a concise thematic account. Results Themes emerged from the review of the literature on RF published in 2022, including a couple of studies on the epidemiology of fasting in the real world by adults and children. Three studies involved some pathophysiological observations of metabolic and other biochemical markers. Several studies assessed the use and safety of different pharmacological therapeutic agents. Certain sulfonylureas, such as modified-release gliclazide, were considered safer than other sulfonylureas. Newer basal insulin analogs were studied in different geographical and socioeconomic settings (Gulf vs. South East Asia). The role of diabetes technology in Ramadan was the focus of several studies of insulin pumps and monitoring. Special themes were high-risk groups, pregnancy, acute complications, postbariatric surgery, and COVID-19 in Ramadan. Few studies examined the safety of sodium-glucose co-transporter-2 inhibitors as a class and individually during RF. Professional and patient perspectives released in 2022 included updated guidelines for adults and adolescents. Conclusions In 2022's medical literature, RF and diabetes continue to address epidemiology, the burden of diabetes care on fasting patients, and discussions of concerns of patients and healthcare professionals. Risk stratification and issues of high-risk patients are still in focus for children, adolescents, and adults. Approaches to effective management still gather evidence for newer pharmacological agents and diabetes technology.

show abstract

Section: Resultsmentioning

confidence: 99%

Ramadan Fasting and Diabetes (2022): The Year in Review

Hafidh

Besheya

Elmehdawi

et al. 2023

Journal of Diabetes and Endocrine Practice

View full text Add to dashboard Cite

show abstract

“…Different aspects of the impact of COVID-19 infection on diabetes for people observing RF were assessed by a few investigators. [47][48][49][50][51] The DaR Global survey was conducted in 13 countries to assess the impact of the COVID-19 pandemic on the intentions to fast and the outcomes of fasting in PWD with chronic kidney disease (CKD). 47 The study included 6,736 PWD, of which 10.5% had CKD.…”

Section: Covid-19mentioning

confidence: 99%

“…Different aspects of the impact of COVID-19 infection on diabetes for people observing RF were assessed by a few investigators. 47 48 49 50 51…”

Section: Highlights Of the Literaturementioning

confidence: 99%

See 1 more Smart Citation

Diabetes and Ramadan Fasting (2023): The Year in Review

Abusahmin,

Abdelgadir,

Eledrisi

et al. 2024

Journal of Diabetes and Endocrine Practice

View full text Add to dashboard Cite

Introduction We aimed to provide an overview of the global literature production on diabetes and Ramadan in the past year (2023). Materials and Methods This is a narrative, nonsystematic review of the international literature from two major medical online databases (PubMed and Google Scholar) in 2023. The search term “Diabetes AND Ramadan fasting” was used, and the relevant literature was narrated in a concise thematic account. Results The publications spanned a vast array of topics related to diabetes and Ramadan fasting (RF), including physiology and nutrition, risk assessment stratification tools and their validation, assessments of safety and efficacy profiles of older and newer diabetes therapies, diabetes education, use of advanced technology for the treatment, and monitoring and impact on pregnancy. Some reports covered the interaction between Ramadan and COVID-19 concerning diabetes, pregnancy, complications, and unique characteristics of diabetes and fasting by young and older people. Conclusion The current narration presents this year's global scholarly production on the safety of fasting practices, care models, and patients' experiences and perspectives.

show abstract

Evaluation of physicians' approaches for the management of patients with diabetes during Ramadan in Iraq

Cited by 2 publications

References 10 publications

Ramadan Fasting and Diabetes (2022): The Year in Review

Ramadan Fasting and Diabetes (2022): The Year in Review

Diabetes and Ramadan Fasting (2023): The Year in Review

Contact Info

Product

Resources

About